European Study on Three Different Approaches to Managing Class 2 Cavities in Primary Teeth
Launched by UNIVERSITY MEDICINE GREIFSWALD · Feb 21, 2013
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
At present, many materials and techniques are used to treat carious primary teeth. All of these have their proponents who claim they provide the best performance in terms of longevity, aesthetics, bio-compatibility, etc (Qvist, 2010; Yengopal et al., 2009). However, despite the great variety of techniques and materials, there is no definite evidence for the most effective approach when dental caries in primary molars is concerned, as yet. On the other hand, there is conclusive evidence that shows that glass-ionomer cement is an inappropriate material for class II restorations in primary tee...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Children aged 3-8 years who attend the Preventive and Paediatric Department of Greifswald University, Germany.
- • (Lithuania: children who attend the paediatric dentistry department, Dental Faculty, Lithuanian University of Health Sciences)
- • At least one primary molar tooth with caries into dentine involving two dental surfaces (diagnosed according to the International Caries Detection and Assessment System \[ICDAS\], codes 3 to 5)
- • Willing to be examined
- Exclusion Criteria:
- • Clinical or radiographic signs of pulpal or peri-radicular pathology
- • Patients with a systemic disease requiring special considerations during their dental treatment.
- • Parents/children who refuse to participate in the study
Trial Officials
Christian H Splieth, Prof. Dr.
Study Chair
University Medicine Greifswald
About University Medicine Greifswald
University Medicine Greifswald is a prominent academic medical center located in Greifswald, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a clinical trial sponsor, it fosters a collaborative environment that integrates cutting-edge scientific inquiry with patient care, focusing on a wide range of medical disciplines. The institution is committed to enhancing patient outcomes by conducting rigorous clinical trials that adhere to the highest ethical standards and regulatory requirements. With a strong emphasis on interdisciplinary collaboration, University Medicine Greifswald aims to contribute significantly to the development of new therapies and medical advancements, ultimately improving healthcare delivery and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Greifswald, Mecklenburg Vorpommern, Germany
Kaunas, , Lithuania
Dundee, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials